Cargando…

A family cluster of SARS-CoV-2 infection involving 11 patients in Nanjing, China

Detalles Bibliográficos
Autores principales:	Huang, Rui, Xia, Juan, Chen, Yuxin, Shan, Chun, Wu, Chao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7159019/ https://www.ncbi.nlm.nih.gov/pubmed/32119823 http://dx.doi.org/10.1016/S1473-3099(20)30147-X

Ejemplares similares

A family cluster of COVID-19 involving an asymptomatic case with persistently positive SARS-CoV-2 in anal swabs
por: Huang, Rui, et al.
Publicado: (2020)

Asymptomatic cases in a family cluster with SARS-CoV-2 infection
por: Pan, Xingfei, et al.
Publicado: (2020)

Serum neutralising activity against SARS-CoV-2 variants elicited by CoronaVac
por: Chen, Yuxin, et al.
Publicado: (2021)

Gastrointestinal involvement of COVID-19 and potential faecal transmission of SARS-CoV-2
por: Song, Min, et al.
Publicado: (2020)

Neutralization of SARS-CoV-2 BQ.1.1, CH.1.1, and XBB.1.5 by breakthrough infection sera from previous and recent waves in China
por: Wang, Xun, et al.
Publicado: (2023)

Identification of SARS-CoV-2 clusters from symptomatic cases in India
por: Jain, Parul, et al.
Publicado: (2020)

Azithromycin Downregulates Gene Expression of IL-1β and Pathways Involving TMPRSS2 and TMPRSS11D Required by SARS-CoV-2
por: Renteria, Axel E., et al.
Publicado: (2020)

Mutations and Phylogenetic Analyses of SARS-CoV-2 Among Imported COVID-19 From Abroad in Nanjing, China
por: Zhao, Ning, et al.
Publicado: (2022)

Attitudes of vaccination service providers to the SARS-CoV-2 intranasal spray vaccine during the SARS-CoV-2 pandemic in China: A cross-sectional study
por: Cao, Yanlin, et al.
Publicado: (2023)

Prevalence and clustering of cardiovascular risk factors: a cross-sectional survey among Nanjing adults in China
por: Hong, Xin, et al.
Publicado: (2018)

Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement
por: Zang, Jinkai, et al.
Publicado: (2020)

Omicron BA.1/1.1 SARS-CoV-2 Infection among Vaccinated Canadian Adults
por: Brown, Patrick E., et al.
Publicado: (2022)

Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1
por: Miller, Jessica, et al.
Publicado: (2023)

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
por: Standl, Fabian, et al.
Publicado: (2021)

Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, China
por: Hoehl, Sebastian, et al.
Publicado: (2020)

SARS-CoV-2 Infection among Travelers Returning from Wuhan, China
por: Ng, Oon-Tek, et al.
Publicado: (2020)

Has China faced only a herald wave of SARS-CoV-2?
por: Flahault, Antoine
Publicado: (2020)

Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization
por: Wang, Guo-Lin, et al.
Publicado: (2021)

Detection of Toxoplasma gondii in chicken and soil of chicken farms in Nanjing region, China
por: Liu, Xin-Chao, et al.
Publicado: (2017)

Efficacy of antivirals and bivalent mRNA vaccines against SARS-CoV-2 isolate CH.1.1
por: Uraki, Ryuta, et al.
Publicado: (2023)

Replicative capacity of SARS-CoV-2 omicron variants BA.5 and BQ.1.1 at elevated temperatures
por: Muramoto, Yukiko, et al.
Publicado: (2023)

May Parkinson's disease be a protective factor against CNS involvement by SARS-CoV2?
por: Spina Tensini, F., et al.
Publicado: (2020)

Safety of protease inhibitors and Arbidol for SARS-CoV-2 pneumonia in Zhejiang Province, China
por: Guo, Yong-zheng, et al.
Publicado: (2020)

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1
por: van Doremalen, Neeltje, et al.
Publicado: (2020)

N(6)-methyladenosine regulates RNA abundance of SARS-CoV-2
por: Zhang, Ting, et al.
Publicado: (2021)

Nanjing scenes.
Publicado: (1988)

SARS-CoV-2 nucleic acid testing is China's key pillar of COVID-19 containment
por: Han, Xiaoxu, et al.
Publicado: (2022)

Structure basis for inhibition of SARS-CoV-2 by the feline drug GC376
por: Luan, Xiao-dong, et al.
Publicado: (2022)

Outpatient strategies and the changing SARS-CoV-2 epidemic
por: Wei, Yanqiu, et al.
Publicado: (2020)

More bricks in the wall against SARS-CoV-2 infection: involvement of γ9δ2 T cells
por: Rijkers, Ger, et al.
Publicado: (2020)

Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection
por: Lin, Qingqing, et al.
Publicado: (2020)

Familial cluster of pneumonia and asymptomatic cases of COVID-19 in Taiwan
por: Chiu, Chun-Hsiang, et al.
Publicado: (2020)

Triazole Resistance in Aspergillus fumigatus Clinical Isolates Obtained in Nanjing, China
por: Zhang, Ming, et al.
Publicado: (2017)

Safety of SARS-CoV-2 vaccines in patients with chronic myeloid leukemia: a multicenter survey in China
por: Yang, Yunfan, et al.
Publicado: (2022)

A case of SARS-CoV-2 reinfection in Ecuador
por: Prado-Vivar, Belén, et al.
Publicado: (2021)

Sunitinib reduces the infection of SARS-CoV, MERS-CoV and SARS-CoV-2 partially by inhibiting AP2M1 phosphorylation
por: Wang, Pei-Gang, et al.
Publicado: (2020)

Antigenic mapping of emerging SARS-CoV-2 omicron variants BM.1.1.1, BQ.1.1, and XBB.1
por: Mykytyn, Anna Z, et al.
Publicado: (2023)

Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV
por: Zheng, Ming, et al.
Publicado: (2020)

SARS-CoV-2 cell tropism and multiorgan infection
por: Liu, Jia, et al.
Publicado: (2021)

Neutralization of the SARS-CoV-2 Deltacron and BA.3 Variants
por: Evans, John P., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cn48c97ba93qplfh3rgt0iml8b